Medical experts have raised alarm over the growing threat of hepatitis in Nigeria as about 20 million people, roughly 10 percent of the country’s population, may be carriers of the virus.
Speaking during a community outreach to mark the 2025 World Hepatitis Day in Abuja, a gastroenterologist at Garki Hospital, Dr Idile Justice, described hepatitis as a silent killer that can lead to liver cancer if not diagnosed and treated early.
READ ALSO: Kano govt begins free Hepatitis B treatment for pregnant women, newborns
Dr Justice said the B and C variants of the virus are especially prevalent in northern Nigeria, adding that they are primarily transmitted through blood transfusion, sharing of sharp objects, and unsafe tattooing practices.
Dr Justice also noted that over 60 percent of liver-related diseases and cancers are linked to hepatitis B and C. He explained that the virus lingers on sharp objects and can be transmitted if these tools are not properly sterilized.
He lamented the low awareness about the disease, noting that many Nigerians are unaware of their status. He called for increased testing and vaccination as preventive steps.
The outreach, with the theme Let’s break it down, was organized by Nisa Garki Hospital in partnership with the Lehi Foundation. It featured free testing and vaccinations both within the hospital premises and at Garki Village in Abuja.
Dr Kenneth Ityo, the Medical Director of Nisa Garki Hospital, emphasized the need for greater public awareness and action. Hepatitis is deadlier than many diseases and often leads to chronic illnesses like liver disease and vascular cancer.
He added that early testing and vaccination are crucial steps in curbing the spread of the disease. Once people know their status, they can begin timely treatment or preventive measures.
Some beneficiaries at the outreach expressed gratitude, saying the free testing helped them gain insight into their health and take proactive steps toward prevention.
According to global health data, over 70 million people in Africa are living with chronic hepatitis B or C, yet fewer than one in ten have been diagnosed or treated.
